These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3727525)

  • 1. [Enhanced immunogenicity of influenza virus surface proteins when incorporated into liposomes].
    Kharitonenkov IG; Iaroslavtseva NG; Isaeva EI; Rovnova ZI; Grigor'ev VB
    Vopr Virusol; 1986; 31(2):162-7. PubMed ID: 3727525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the glycoproteins of vaccinal strains of the influenza viruses solubilized by octyl-beta-D-glucopyranoside].
    Mel'nikov SK; Busygina OG; Shekut'eva NA; Reĭngol'd VN; Chumakov MP
    Vopr Virusol; 1985; 30(2):153-8. PubMed ID: 4002689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of influenza virus haemagglutinin with phospholipid vesicles - morphological and immunological studies.
    Oxford JS; Hockley DJ; Heath TD; Patterson S
    J Gen Virol; 1981 Feb; 52(Pt 2):329-43. PubMed ID: 7288397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and studies of myxovirus glycoproteins.
    Berezin VA; Zaides VM; Artamonov AF; Isaeva ES; Zhdanov VM
    Arch Virol; 1985; 85(3-4):281-300. PubMed ID: 2992420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity of a subunit influenza vaccine in experiments on animals].
    Berezin VE; Zaĭdes VM; Isaeva ES; Zhdanov VM
    Vopr Virusol; 1985; 30(2):166-74. PubMed ID: 4002691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross reactivity of the cytotoxic lymphocytes of mice immunized with the virions of pathogenic and nonpathogenic influenza virus strains and membrane protein].
    Andzhaparidze OG; Sorokina IuD; Chernushkina AV; Ageeva ON
    Vopr Virusol; 1983; (2):136-9. PubMed ID: 6603070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibility of detecting the matrix protein of the influenza virus in intact and disrupted virions by immunoenzyme analysis and immune electron microscopy].
    Busse TL; Khristova ML; Makhov AM; Zagidullin NV; Klimenko SM
    Vopr Virusol; 1986; 31(5):544-9. PubMed ID: 3541386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparative isolation of myxovirus glycoproteins and the study of their immunogenic properties].
    Berezin VE; Zaĭdes VM; Mchedlishvili BV; Selimova LM; Kliushnik SIu
    Mol Gen Mikrobiol Virusol; 1985 Jul; (7):36-43. PubMed ID: 3025716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and immunogenic characteristics of rabies immunosomes.
    Perrin P; Sureau P; Thibodeau L
    Dev Biol Stand; 1985; 60():483-91. PubMed ID: 4043539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to rubella virus proteins in different physical forms.
    Trudel M; Nadon F; Comtois R; Ravaoarinoro M; Payment P
    Antiviral Res; 1982 Dec; 2(6):347-54. PubMed ID: 7165297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
    de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
    Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane fusion activity of reconstituted vesicles of influenza virus hemagglutinin glycoproteins.
    Kawasaki K; Sato SB; Ohnishi S
    Biochim Biophys Acta; 1983 Sep; 733(2):286-90. PubMed ID: 6309232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes.
    Koszinowski UH; Allen H; Gething MJ; Waterfield MD; Klenk HD
    J Exp Med; 1980 Apr; 151(4):945-58. PubMed ID: 6154763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhanced immunogenicity of influenza virus hemagglutinin when incorporated into liposomes].
    Ishbaeva RI; Guliako AA; Simonov AN; Kleppish I; Makhov AM
    Vopr Virusol; 1989; 34(2):237-40. PubMed ID: 2763517
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the antigenic properties of influenza virus after sugar cleavage].
    Shenderovich SF; Zakstel'skaia LIa; Berezin VE; Kharitonenkov IG
    Vopr Virusol; 1980; (4):412-5. PubMed ID: 7423969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of purified glycoproteins of influenza virus and analysis of their antigenic and immunogenic activity].
    Berezin VE; Isaeva ES; Artamonov AF; Zaĭdes VM; Zhdanov VM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):81-8. PubMed ID: 6193663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional reconstitution of the integral membrane proteins of influenza virus into phospholipid liposomes.
    Sizer PJ; Miller A; Watts A
    Biochemistry; 1987 Aug; 26(16):5106-13. PubMed ID: 3663646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of agarose for isolating influenza virus proteins retaining a high immunogenicity].
    Ivanova VT; Zakstel'skaia LIa; Trushinskaia GN; Shenderovich SF; Liubovtseva OV
    Vopr Virusol; 1983; 28(4):32-5. PubMed ID: 6356601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virosome preparation: differences between influenza and rubella hemagglutinin adsorption.
    Trudel M; Nadon F
    Can J Microbiol; 1981 Sep; 27(9):958-62. PubMed ID: 7306885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.